U4L

(4P)-4-(5-methyl-1H-indazol-4-yl)-6-(2-propanoyl-2,6-diazaspiro[3.4]octan-6-yl)-2-(pyrrolidin-1-yl)pyrimidine-5-carbonitrile

Created:	2022-08-04
Last modified:	2024-09-27

Find Related PDB Entry
1 entries where U4L is covalently linked to polymer or other heterogen groups

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	65
Chiral Atom Count	0
Bond Count	70
Aromatic Bond Count	16

2D diagram of U4L

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(4P)-4-(5-methyl-1H-indazol-4-yl)-6-(2-propanoyl-2,6-diazaspiro[3.4]octan-6-yl)-2-(pyrrolidin-1-yl)pyrimidine-5-carbonitrile
Systematic Name (OpenEye OEToolkits)	4-(5-methyl-1~{H}-indazol-4-yl)-6-(2-propanoyl-2,7-diazaspiro[3.4]octan-7-yl)-2-pyrrolidin-1-yl-pyrimidine-5-carbonitrile
Formula	C₂₆ H₃₀ N₈ O
Molecular Weight	470.569
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	CCC(=O)N1CC2(CCN(C2)c2nc(nc(c3c(C)ccc4[NH]ncc34)c2C#N)N2CCCC2)C1
SMILES	CACTVS	3.385	CCC(=O)N1CC2(CCN(C2)c3nc(nc(c3C#N)c4c(C)ccc5[nH]ncc45)N6CCCC6)C1
SMILES	OpenEye OEToolkits	2.0.7	CCC(=O)N1CC2(C1)CCN(C2)c3c(c(nc(n3)N4CCCC4)c5c(ccc6c5cn[nH]6)C)C#N
Canonical SMILES	CACTVS	3.385	CCC(=O)N1CC2(CCN(C2)c3nc(nc(c3C#N)c4c(C)ccc5[nH]ncc45)N6CCCC6)C1
Canonical SMILES	OpenEye OEToolkits	2.0.7	CCC(=O)N1CC2(C1)CCN(C2)c3c(c(nc(n3)N4CCCC4)c5c(ccc6c5cn[nH]6)C)C#N
InChI	InChI	1.06	InChI=1S/C26H30N8O/c1-3-21(35)34-15-26(16-34)8-11-33(14-26)24-18(12-27)23(29-25(30-24)32-9-4-5-10-32)22-17(2)6-7-20-19(22)13-28-31-20/h6-7,13H,3-5,8-11,14-16H2,1-2H3,(H,28,31)
InChIKey	InChI	1.06	FTVJMOHSJKCESM-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
PubChem	164885979

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.